SHARON EKEDAHL: Open Payments
NPI 1982038121 · MARYSVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 7 companies in 2025. Trend: 2023 $138 · 2024 $139 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $72 |
| Lilly USA, LLC | 3 | $54 |
| PFIZER INC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Astellas Pharma US Inc | 1 | $28 |
| Novo Nordisk Inc | 1 | $15 |
Products named: JOURNAVX, MOUNJARO, ROTATEQ, Veozah, ELIQUIS, NURTEC ODT, Ozempic, FARXIGA.
Industry payments across CA — which companies pay providers there.
